We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
+8.01%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$39.1B
AUM Growth
+$2.42B
(+6.6%)
Cap. Flow
-$248M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
22.64%
Holding
3,845
New
218
Increased
1,110
Reduced
1,483
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell Mid-Cap ETF
IWR
|
+$45.6M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$40.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$38.8M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$35.5M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$34.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$80.2M |
| 2 |
Copart
CPRT
|
+$55.9M |
| 3 |
US Bancorp
USB
|
+$47.8M |
| 4 |
IBDK
iShares iBonds Dec 2019 Term Corporate ETF
IBDK
|
+$25.8M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$17.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.27% |
| 2 | Financials | 10.78% |
| 3 | Industrials | 9.91% |
| 4 | Healthcare | 9.19% |
| 5 | Consumer Staples | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Vanguard Small-Cap ETF
VB
$79.5B
| $15M | 0.04% |
90,816
+2,185
| +2% | +$348K |
|
302
Graco
GGG
$12.9B
| $15M | 0.04% |
289,075
+7,683
| +3% | +$367K |
|
303
Elevance Health
ELV
$81.9B
| $14.8M | 0.04% |
48,958
-308
| -0.6% | -$84.8K |
|
304
iShares MSCI KLD 400 Social ETF
DSI
$5.19B
| $14.8M | 0.04% |
246,136
+5,296
| +2% | +$304K |
|
305
Canadian National Railway
CNI
$78.5B
| $14.7M | 0.04% |
162,593
-5,920
| -4% | -$532K |
|
306
Yum! Brands
YUM
$41B
| $14.6M | 0.04% |
144,503
+1,018
| +0.7% | +$105K |
|
|
IBMJ
307
DELISTED
iShares iBonds Dec 2021 Term Muni Bond ETF
IBMJ
| $14.5M | 0.04% |
564,254
+9,875
| +2% | +$255K |
|
308
Masco
MAS
$16B
| $14.5M | 0.04% |
302,613
+2,702
| +0.9% | +$123K |
|
309
CMS Energy
CMS
$23.1B
| $14.4M | 0.04% |
229,569
-888
| -0.4% | -$55.4K |
|
|
FL
310
DELISTED
Foot Locker
FL
| $14.4M | 0.04% |
368,402
-35,248
| -9% | -$1.48M |
|
311
Ross Stores
ROST
$76.6B
| $14.1M | 0.04% |
121,463
-19,715
| -14% | -$2.22M |
|
312
Intuitive Surgical
ISRG
$121B
| $13.6M | 0.03% |
69,108
+4,188
| +6% | +$784K |
|
313
iShares MSCI ACWI ex US ETF
ACWX
$11.3B
| $13.6M | 0.03% |
276,259
+19,056
| +7% | +$909K |
|
314
Zoetis
ZTS
$31.6B
| $13.6M | 0.03% |
102,481
+1,945
| +2% | +$242K |
|
315
Hershey
HSY
$35.4B
| $13.5M | 0.03% |
91,794
-572
| -0.6% | -$84.8K |
|
316
McCormick & Company Non-Voting
MKC
$13.4B
| $13.4M | 0.03% |
157,592
-6,372
| -4% | -$527K |
|
|
IBDO
317
DELISTED
iShares iBonds Dec 2023 Term Corporate ETF
IBDO
| $13.3M | 0.03% |
521,694
+45,259
| +9% | +$1.16M |
|
318
iShares Currency Hedged MSCI Japan ETF
HEWJ
$728M
| $13.3M | 0.03% |
403,056
-49,260
| -11% | -$1.61M |
|
319
Lam Research
LRCX
$382B
| $13.3M | 0.03% |
453,500
-1,450
| -0.3% | -$38.5K |
|
320
Paychex
PAYX
$40.4B
| $13M | 0.03% |
153,192
-1,714
| -1% | -$145K |
|
321
Roper Technologies
ROP
$36.3B
| $13M | 0.03% |
36,768
+150
| +0.4% | +$51.8K |
|
322
Amcor
AMCR
$20.6B
| $13M | 0.03% |
239,661
-17,949
| -7% | -$899K |
|
323
Check Point Software Technologies
CHKP
$13.3B
| $12.9M | 0.03% |
116,290
-2,916
| -2% | -$328K |
|
324
Motorola Solutions
MSI
$69.4B
| $12.9M | 0.03% |
79,838
+40,884
| +105% | +$6.73M |
|
325
Cognex
CGNX
$10.3B
| $12.7M | 0.03% |
227,232
-67,345
| -23% | -$3.48M |
|
Similar funds
US Bancorp's Q4 2019 Portfolio in Review
As of Q4 2019, US Bancorp held 3,845 positions worth $39.1B, up 6.6% from $36.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
US Bancorp's Q4 2019 filing shows 218 new, 1,110 increased, 1,483 reduced and 148 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $80.2M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
- US Bancorp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M.
- US Bancorp added most to iShares Russell Mid-Cap ETF in Q4 2019, an estimated $45.6M increase.
- US Bancorp's biggest Q4 2019 reduction was Copart, cutting an estimated $55.9M.
- US Bancorp fully exited Celgene Corp in Q4 2019, selling an estimated $80.2M.
- US Bancorp's ten largest holdings make up 23% of its $39.1B portfolio in Q4 2019.
- US Bancorp opened 218 new positions and closed 148 in Q4 2019.
- US Bancorp's portfolio value rose 6.6% quarter-over-quarter to $39.1B.
Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.